Avricore Health Finalizes Agreement With Avrok Laboratories to Offer Real-Time Covid-19 Screening Medical Device Investing
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates Pharmaceutical Investing
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BELLUS Health Inc. - BLU Biotech Investing
BLU ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 17, 2021 in the Class Action Filed on Behalf of BELLUS Health Inc. Limited Shareholders Biotech Investing
BELLUS HEALTH ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Bellus Health, Inc. and Encourages Investors to Contact the Firm Biotech Investing
INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BELLUS Health Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - BLU Biotech Investing
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
Lowey Dannenberg, P.C. Announces Filing of Securities Class Action Lawsuit Against Bellus Health Inc. on Behalf of Investors Who Acquired Shares from September 19, 2019 to July 5, 2020 and Encourages Investors to Inquire About the Lead Plaintiff Position Before the May 17, 2021 Lead Plaintiff Deadline Biotech Investing
Merck Announces Filing of Form 10 Registration Statement in Connection with Planned Spinoff of Organon & Co. Pharmaceutical Investing
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of BELLUS Health Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 17, 2021 - BLU Biotech Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness
